News
TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products
22 Jan 2019
8 May 2018
TCB wins High Growth Company of the Year
16 May 2018
14 February 2018
TC BioPharm Opens First Overseas Office in Japan
TC BioPharm wins Life Sciences Company of the Year 2018
27 April 2018
07 February 2018
TC BioPharm and the NIPRO Corporation Announce Strategic Collaboration
TC Biopharm Announces Strategic Collaboration with bluebird bio
08 December 2017
06 Sep 2017
TC BioPharm Announces CAR-T Licensing Deal With UCL Business
TCB Selected For EU Horizon 2020 Funding to Progress Novel, Mass-Market Cell Therapies to Clinical Trial
02 August 2017
02 February 2017
TCB wins ‘Entrepreneurial Business Leadership Award’
Scottish immunotherapy company raises over £6m for innovative cancer treatments
30 January 2017
09 September 2015
TC BioPharm granted approval to treat cancer patients
TC BioPharm starts clinical study in cancer patients
16 December 2015
31 August 2015
Investing Women appoint Director to TC BioPharm Board
TC BioPharm Ltd raises £1.2m to commence treatment of UK cancer patients
13 July 2015
07 January 2015
TC BioPharm gets green light for cancer trial